Studies on the obestatin/ghrelin ratio in the gastrointestinal tract and plasma are associated with some diseases such as irritable bowel syndrome [9], obesity [10] and type 2 diabetes mellitus [11]. This evidence concerns the gene GHRL and obesity disorder.